Rallybio Corporation announced that Ami Bavishi has joined as the company's Head of Investor Relations and Corporate Communications. Ms. Bavishi brings more than 10 years of experience to Rallybio and will be responsible for overseeing Rallybio's investor relations (IR) and communications efforts, including shaping the company's IR and communications strategies. She will report to Steven Tuch, the company's Head of Corporate Development.

Prior to joining Rallybio, Ms. Bavishi was Director of Investor Relations at Aerie Pharmaceuticals Inc., where she oversaw all investor relations activities. Prior to Aerie, she held positions of increasing responsibility at Burns McClellan, a life sciences investor relations and public relations firm, including Vice President of Investor Relations. At Burns McClellan, Ms. Bavishi oversaw day-to-day investor relations and communications activities for multiple biotechnology companies.